Evaluation of HBED-PSMA-Ga68 kits for prostate cancer biochemical recurrence diagnostic

Trial Profile

Evaluation of HBED-PSMA-Ga68 kits for prostate cancer biochemical recurrence diagnostic

Not yet recruiting
Phase of Trial: Phase III

Latest Information Update: 19 Dec 2016

At a glance

  • Drugs Gallium 68 PSMA (Primary)
  • Indications Prostate cancer
  • Focus Diagnostic use
  • Sponsors Radiopharmacus
  • Most Recent Events

    • 19 Dec 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top